In_FW
vivo_FW
modification_NN
of_IN
major_JJ
histocompatibility_NN
complex_NN
class_NN
II_CD
DRA_NN
promoter_NN
occupancy_NN
mediated_VBN
by_IN
the_DT
AIR-1_NN
trans-activator_NN
._.

RJ_NN
2.2.5_CD
is_VBZ
a_DT
human_JJ
B_NN
cell_NN
mutant_NN
derived_VBN
from_IN
the_DT
Burkitt_NN
lymphoma_NN
Raji_NN
cell_NN
which_WDT
is_VBZ
defective_JJ
in_IN
the_DT
AIR-1_NN
locus_NN
function_NN
._.

This_DT
locus_NN
encodes_VBZ
a_DT
transcriptional_JJ
trans-activator_NN
required_VBN
for_IN
the_DT
constitutive_JJ
expression_NN
of_IN
major_JJ
histocompatibility_NN
complex_NN
-LRB-_-LRB-
MHC_NN
-RRB-_-RRB-
class_NN
II_CD
genes_NNS
._.

Here_RB
we_PRP
show_VBP
,_,
by_IN
in_FW
vivo_FW
DNase_NN
I_NN
footprinting_NN
,_,
that_IN
the_DT
AIR-1_NN
locus_NN
defect_NN
correlates_VBZ
with_IN
changes_NNS
in_IN
the_DT
DRA_NN
promoter_NN
occupancy_NN
._.

Interestingly_RB
,_,
reexpression_NN
of_IN
human_JJ
MHC_NN
class_NN
II_CD
genes_NNS
in_IN
RJ_NN
2.2.5_CD
x_NN
mouse_NN
spleen_NN
cell_NN
hybrids_NNS
is_VBZ
associated_VBN
with_IN
partial_JJ
reversion_NN
of_IN
DRA_NN
promoter_NN
occupancy_NN
to_TO
the_DT
Raji_NN
pattern_NN
._.

DRA_NN
promoter_NN
occupancy_NN
in_IN
other_JJ
class_NN
II-negative_JJ
B_NN
cell_NN
lines_NNS
,_,
derived_VBN
from_IN
patients_NNS
with_IN
bare_JJ
lymphocyte_NN
syndrome_NN
,_,
is_VBZ
drastically_RB
different_JJ
from_IN
the_DT
one_CD
observed_VBN
in_IN
RJ_NN
2.2.5_CD
and_CC
Raji_NN
cells_NNS
._.

Moreover_RB
,_,
the_DT
use_NN
of_IN
the_DT
DNase_NN
I_NN
as_IN
an_DT
in_FW
vivo_FW
footprinting_NN
agent_NN
reveals_VBZ
that_IN
the_DT
patients_NNS
'_POS
cell_NN
lines_NNS
do_VBP
not_RB
display_VB
a_DT
completely_RB
``_JJ
bare_JJ
promoter_NN
''_NN
as_IN
previously_RB
reported_VBN
using_VBG
dimethyl_JJ
sulfate_NN
as_IN
the_DT
footprinting_NN
agent_NN
._.

Thus_RB
,_,
the_DT
use_NN
of_IN
DNase_NN
I_NN
allowed_VBD
us_PRP
,_,
for_IN
the_DT
first_JJ
time_NN
,_,
to_TO
correlate_VB
the_DT
AIR-1_NN
locus_NN
defect_NN
with_IN
class_NN
II_CD
promoter_NN
occupancy_NN
alterations_NNS
and_CC
distinguish_VB
these_DT
alterations_NNS
from_IN
the_DT
ones_NNS
observed_VBN
in_IN
phenotypically_RB
similar_JJ
but_CC
genetically_RB
distinct_JJ
MHC_NN
class_NN
II-negative_JJ
cells_NNS
._.

